SEC Company Response from SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. (CIK 0000806592) — Nov 4, 2005
SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. (CIK 0000806592)
Date: Nov. 4, 2005 · CIK: 0000806592 · Accession: 0001172665-05-000584
AI Filing Summary & Sentiment
File numbers found in text: 333-125300
Letter
Re: Sunwin International Neutraceuticals, Inc. (the "Company") Registration Statement on Form SB-2 File Number 333-125300
Sunwin International Neutraceuticals, Inc 6 Youpeng Road Qufu, Shandong, China
November 4, 2005
United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549
Attention: Jeffrey Riedler Dana Hartz Joel Parker Zafar Hasan
Ladies and Gentlemen:
The undersigned registrant hereby requests acceleration of the effective date of the above-captioned Registration Statement to Tuesday, November 8, 2005 at 4:00 p.m., Eastern Daylight time, or as soon thereafter as is practicable.
The undersigned registrant acknowledges that:
o Should the Securities and Exchange Commission (the "Commission") or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
o The action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the registrant from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
o The registrant may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
The undersigned also acknowledges to the Staff its awareness of its responsibilities under the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended.
Very truly yours,
SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC.
Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
Sunwin International Neutraceuticals, Inc
6 Youpeng Road
Qufu, Shandong, China
November 4, 2005
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jeffrey Riedler
Dana Hartz
Joel Parker
Zafar Hasan
Re: Sunwin International Neutraceuticals, Inc. (the "Company")
Registration Statement on Form SB-2
File Number 333-125300
Ladies and Gentlemen:
The undersigned registrant hereby requests acceleration of the
effective date of the above-captioned Registration Statement to Tuesday,
November 8, 2005 at 4:00 p.m., Eastern Daylight time, or as soon thereafter as
is practicable.
The undersigned registrant acknowledges that:
o Should the Securities and Exchange Commission (the "Commission")
or the staff, acting pursuant to delegated authority, declare the
filing effective, it does not foreclose the Commission from
taking any action with respect to the filing;
o The action of the Commission or the staff, acting pursuant to
delegated authority, in declaring the filing effective, does not
relieve the registrant from its full responsibility for the
adequacy and accuracy of the disclosure in the filing; and
o The registrant may not assert staff comments and the declaration
of effectiveness as a defense in any proceeding initiated by the
Commission or any person under the federal securities laws of the
United States.
The undersigned also acknowledges to the Staff its awareness of its
responsibilities under the Securities Act of 1933 and the Securities Exchange
Act of 1934, as amended.
Very truly yours,
SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC.
By: /s/ Dongdong Lin
---------------------------
Dongdong Lin,
Principal Executive Officer
</TEXT>
</DOCUMENT>